Gilead Sciences (NASDAQ:GILD) just reported results for the second quarter of 2024.
- Gilead Sciences reported earnings per share of $2.01. This was above the analyst estimate for EPS of $1.60.
- The company reported revenue of $6.95 billion.
- This was 3.48% better than the analyst estimate for revenue of $6.72 billion.